期刊文献+

2型糖尿病患者糖化血红蛋白与甲状腺激素水平分析 被引量:3

The analysis of the correlation of the levels of glycosylated hemoglobin A1c and thyroid hormone in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的分析2型糖尿病患者糖化血红蛋白(HbA1c)与甲状腺激素水平的相关性,探讨长期血糖控制对糖尿病甲状腺功能影响的临床意义。方法采用化学发光法检测2型糖尿病及健康对照组游离三碘甲腺原氨酸(FT3)、游离甲状腺素(FT4)、超敏促甲状腺素(S-TSH),使用高效液相色谱仪分析HbA1c,同时分析受试者空腹血糖(FBG)。结果 2型糖尿病组FT3低于正常对照组(P<0.01),S-TSH高于对照组(P<0.01),FT4低于对照组,但差异无显著性(P>0.05);2型糖尿病患者FBG与HbA1c量成正相关(P<0.01),HbA1c与FT3浓度成负相关(P<0.05)。结论 2型糖尿病患者甲状腺激素水平紊乱增多且与长期高血糖相关。 Objective To investigate the effects of longterm control of blood sugar in patients with type 2 diabetes mellitus by analyzing the correlation of the levels of glycosylated hemoglobinAlc (HbAlc) and thyroid hormone. Methods A chemiluminescence method was used to determine the serum concentrations of FT3, FT4 and S - TSH in patients with type 2 diabetes mellitus and in healthy control group. Meanwhile a High Performance Liquid Chromatography (HPLC) was used to analyze the glycosylated hemoglobinAlc (HbAlc) and the fasting blood glucose (FBG) in patients with type 2 diabetes mellitus (type 2 diabetes mellitus group) and in healthy control group. Results In the type 2 diabetes mellitus group, FT3 lowered, there was statistically significant difference ( P 〈 0.01), compared t9 the control group, S-TSH was higher than those in the control group ( P 〈 0.01), and the FT4 was lower, but there was no statistical difference, conpared to those in the control group ( P 〉0.05). In patients with type 2 diabetes mellitus, FBG is positively associated with the concentrations of HbAlc ( P 〈 0.01), and is negatively associated with FT3 ( P 〈0.05). Conclusion The serun levels of thyroid horme disorder improves and is related to longterm high blood sugar in patients with type 2 diabetes mellitus.
出处 《右江民族医学院学报》 2011年第1期11-13,共3页 Journal of Youjiang Medical University for Nationalities
关键词 2型糖尿病 甲状腺激素类 血红蛋白A 糖基化 diabetes mellitus, type 2 thyroid hormones hemoglobin A, glycosylated
  • 相关文献

参考文献2

二级参考文献76

  • 1刘薇,杨金奎.亚临床甲状腺机能减退研究进展[J].临床荟萃,2007,22(4):293-296. 被引量:15
  • 2Reusch JE.Diabetes,microvascular complications,and cardiovascular complications:what is it about glucose? J Clin Invest 2003;112:986-988.
  • 3LeRoith D.Beta-cell dysfunction and insulin resistance in type 2 diabetes:role of metabolic and genetic abnormalities.Am J Med 2002;113 Suppl 6A:3S-11S.
  • 4Dubois M,Vacher P,Roger B,Huyghe D,Vandewalle B,Kerr-Conte J,Pattou F,Mousta?d-Moussa N,Lang J.Glucotoxicity inhibits late steps of insulin exocytosis.Endocrinology 2007;148:1605-1614.
  • 5Meyer C,Dostou JM,Welle SL,Gerich JE.Role of human liver,kidney,and skeletal muscle in postprandial glucose homeostasis.Am J Physiol Endocrinol Metab 2002;282:E419-E427.
  • 6Dunger DB.Insulin and insulin-like growth factors in diabetes mellitus.Arch Dis Child 1995;72:469-471.
  • 7Gerich JE,Campbell PJ.Overview of counterregulation and its abnormalities in diabetes mellitus and other conditions.Diabetes Metab Rev 1988;4:93-111.
  • 8Krinsley JS.Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.Mayo Clin Proc 2003;78:1471-1478.
  • 9Tiedge M,Lortz S,Drinkgern J,Lenzen S.Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells.Diabetes 1997;46:1733-1742.
  • 10Robertson RP.Oxidative stress and impaired insulin secretion in type 2 diabetes.Curr Opin Pharmacol 2006;6:615-619.

共引文献52

同被引文献18

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部